{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:44:07Z","timestamp":1771645447578,"version":"3.50.1"},"reference-count":44,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4142,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1368-5031.2004.00127.x","type":"journal-article","created":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T16:38:46Z","timestamp":1083256726000},"page":"346-353","source":"Crossref","is-referenced-by-count":32,"title":["Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study"],"prefix":"10.1155","volume":"58","author":[{"given":"R.","family":"Moretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Antonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cazzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Griggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ukmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2004,4,29]]},"reference":[{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1212\/WNL.44.9.1593","article-title":"Prevalence and types of dementia in the very old. Results from the Canadian Study of Health and Aging","volume":"44","author":"Ebly","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00023210-199912010-00004","article-title":"Cerebrovascular dementia. Pathophysiology, diagnosis and treatment","volume":"12","author":"Erkinjuntti","year":"1999","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB3|cit3","first-page":"S59","article-title":"Subtypes of vascular dementia","volume":"13","author":"Rockwood","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1212\/WNL.58.2.209","article-title":"Incidence of AD may decline in the early 90s for men, later for women","volume":"58","author":"Miech","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/brcg.1996.0045","article-title":"Neuropsychological aspects of vascular dementia","volume":"31","author":"McPherson","year":"1996","journal-title":"Brain Cogn"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/WNL.53.4.670","article-title":"Differentiation of vascular dementia from AD on neuropsychological tests","volume":"53","author":"Looi","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB7|cit7","volume-title":"Dementia associated with subcortical ischemic vascular disease","author":"Chui","year":"2001"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.1989.tb05688.x","article-title":"Randomized clinical trial of daily aspirin in multi-infarct dementia. A pilot study","volume":"37","author":"Meyer","year":"1989","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB9|cit9","first-page":"CD000147","article-title":"Nimodipine for primary degenerative, mixed and vascular dementia","volume":"3","author":"Lopez-Arrieta","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB10|cit10","first-page":"163","article-title":"The neurochemistry of vascular dementia","volume":"5","author":"Gottfries","year":"1994","journal-title":"Dementia"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/BF01271206","article-title":"Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer type dementia","volume":"103","author":"Tohgi","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00023210-199912040-00005","article-title":"Selectivity of cholinesterase inhibition","volume":"12","author":"Weinstock","year":"1999","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/nbdi.2001.0462","article-title":"Widely spread butyrylcholinesterase can hydrolize acetylcholine in the normal and Alzheimer brain","volume":"9","author":"Mesulam","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007990152673800","article-title":"A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase","volume":"17","author":"Greig","year":"2001","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000047952","article-title":"Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition","volume":"47","author":"Ballard","year":"2002","journal-title":"Eur Neurol"},{"issue":"Suppl. 127","key":"10.1111\/j.1368-5031.2004.00127.x-BIB16|cit16","first-page":"6","article-title":"Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action","author":"Poirier","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-1331.2001.00224.x","article-title":"Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow up","volume":"8","author":"Moretti","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-510X(02)00280-0","article-title":"Rivastigmine in subcortical vascular dementia: an open 22-month study","volume":"203-204","author":"Moretti","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB20|cit20","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association.","year":"1994"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e0n","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0404.1987.tb07931.x","article-title":"CT in the differential diagnosis between Alzheimer's disease and vascular dementia","volume":"75","author":"Erkinjuntti","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0011-393X(98)85048-0","article-title":"Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type","volume":"59","author":"Agid","year":"1998","journal-title":"Curr Ther Res"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration.","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB25|cit25","first-page":"214","article-title":"The Modified Mini-Mental State (3MS) examination","volume":"48","author":"Teng","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB26|cit26","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"1995"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB27|cit27","unstructured":"Wechsler D. Psychological Corp 1981"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB28|cit28","first-page":"469","article-title":"The utility of the ten-point clock test as a screen for cognitive impairment in general hospital patients","volume":"8","author":"Manos","year":"1997","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB29|cit29","first-page":"61","article-title":"Functional evaluation: the Barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Maryland State Med J"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"issue":"S","key":"10.1111\/j.1368-5031.2004.00127.x-BIB31|cit31","first-page":"9","article-title":"Behavioural symptoms in Alzheimer's disease: phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00002093-198802040-00003","article-title":"Aggressive behaviour in persons with dementia who live in the community","volume":"2","author":"Ryden","year":"1988","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1983","journal-title":"J Psych Res"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1532-5415.1993.tb05945.x","article-title":"Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating scale","volume":"41","author":"Conwell","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1532-5415.1995.tb06377.x","article-title":"Validation of the Cumulative Illness Rating scale in a geriatric residential population","volume":"43","author":"Parmalee","year":"1995","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0011-393X(02)80050-9","article-title":"An open-label pilot study comparing rivastigmine and low-dose aspirin for the treatment of symptoms specific to patients with subcortical vascular dementia","volume":"63","author":"Moretti","year":"2002","journal-title":"Curr Ther Res"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","article-title":"Donepezil in vascular dementia: a randomized, placebo-controlled study","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.STR.0000091396.95360.E1","article-title":"Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","volume":"34","author":"Black","year":"2003","journal-title":"Stroke"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2004.00127.x-BIB39|cit39","first-page":"A141","article-title":"A comparison of the cognitive benefits of donepezil in patients with cortical versus subcortical vascular dementia: a subanalysis of two 24-week, randomized, double-blind, placebo-controlled trials","volume":"60","author":"Salloway","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB40|cit40","unstructured":"Sharma T Kumari V Mitterschiffthaler M et al. Cognitive Effects of Rivastigmine in Alzheimer's Disease: an FMRI Study."},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00001756-200201210-00020","article-title":"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease","volume":"13","author":"Venneri","year":"2002","journal-title":"Neuroreport"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jnnp.73.6.665","article-title":"Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease","volume":"73","author":"Rombouts","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z","article-title":"Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation","volume":"393","author":"Darvesh","year":"1998","journal-title":"J Comparative Neurol"},{"key":"10.1111\/j.1368-5031.2004.00127.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1742-1241.2003.tb10609.x","article-title":"Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in the Alzheimer brain","volume":"57","author":"Erkinjuntti","year":"2003","journal-title":"Int J Clin Pract"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1368-5031.2004.00127.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1368-5031.2004.00127.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:12:32Z","timestamp":1682691152000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1368-5031.2004.00127.x"}},"subtitle":["Rivastigmine Superior to Aspirin Plus Nimodipine"],"short-title":[],"issued":{"date-parts":[[2004,4,29]]},"references-count":44,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1111\/j.1368-5031.2004.00127.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4,29]]}}}